The key products and services being delivered under the federal contract IDV award to Amylyx Pharmaceuticals Inc. (doing business as Amylyx) are the procurement of RELYVRIO, an FDA-approved treatment for amyotrophic lateral sclerosis (ALS), for the U.S. Department of Veterans Affairs (VA). Amylyx, a self-certified small disadvantaged business, has secured multiple contract vehicles with the VA to facilitate the distribution of its pharmaceutical products to veterans, including a Federal Supply Schedule (FSS) contract valued at $225,000 and two Blanket Purchase Agreements (BPAs) valued at $50,000 each.
Under these contract vehicles, the VA has awarded firm-fixed-price delivery orders to Amylyx for the provision of RELYVRIO to various Veterans Integrated Service Networks (VISNs) across the country, primarily in the western United States. The delivery orders range in value from approximately $10,000 to $355,000, with performance periods typically spanning a few months. The place of performance for these contracts is usually Amylyx's headquarters in Cambridge, Massachusetts, or VA medical facilities in cities such as Palo Alto, California, and Seattle, Washington. These contract mechanisms enable VA facilities nationwide to efficiently order RELYVRIO and other Amylyx products as needed to support the healthcare services provided to veterans.
Generated 2/11/25, 10:08 AM